Substance Use Disorders (SUD) Clinical Trial
Official title:
A Phase 1, Double-Blind, Sponsor-Open, Placebo-Controlled, First-In-Human Trial To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Ascending Doses of CVL-936 In Healthy Subjects
The aim of this trial is to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CVL-936 following single ascending oral doses in healthy subjects.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01885026 -
Substance-focused SBI as a Complement to Internet-based Psychiatric Treatment: RCT
|
N/A |